ArticleFrontiers in oncology2025

Safety and efficacy of the combination of selpercatinib with osimertinib in NSCLC: a case report and review of the literature.

Blerina Resuli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.